IMAX Corporation Derivative Instruments, Gain Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing
IMAX Corporation (IMAX) reported Derivative Instruments, Gain Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-10-31.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTesting · last filed 2024-02-27
- IMAX Corporation derivative instruments, gain recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- IMAX Corporation derivative instruments, gain recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- IMAX Corporation derivative instruments, gain recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- IMAX Corporation derivative instruments, gain recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2021-12-31 was $0.00.
- IMAX Corporation derivative instruments, gain recognized in income, ineffective portion and amount excluded from effectiveness testing for fiscal 2021 was $318.00K.
| Period end | Derivative Instruments, Gain Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 3 month | Derivative Instruments, Gain Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 6 month | Derivative Instruments, Gain Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 9 month | Derivative Instruments, Gain Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2022-10-31 | $0.00 10-Q · filed 2022-10-31 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $0.00 10-Q · filed 2022-07-29 | $0.00 10-Q · filed 2022-07-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $25.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $25.00K derived: sum of 3 quarters · filed 2024-02-27 | $296.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $25.00K derived: sum of 2 quarters · filed 2024-02-27 | $296.00K derived: sum of 3 quarters · filed 2024-02-27 | $318.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $25.00K 10-Q · filed 2022-10-31 | $296.00K derived: sum of 2 quarters · filed 2022-10-31 | $318.00K 10-Q · filed 2022-10-31 | |
| 2021-06-30 | $271.00K 10-Q · filed 2022-07-29 | $293.00K 10-Q · filed 2022-07-29 | ||
| 2021-03-31 | $22.00K 10-Q · filed 2022-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EASTMAN KODAK CO (KODK) | United States | $0.931B | -9.63 |
| MOVING iMAGE TECHNOLOGIES INC. (MITQ) | United States | $0.006B | -33.56 |